• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Geriatric assessment-derived deficit accumulation and patient-reported treatment burden in older adults with bladder cancer.老年评估衍生的缺陷积累和老年膀胱癌患者的报告治疗负担。
J Am Geriatr Soc. 2024 Feb;72(2):490-502. doi: 10.1111/jgs.18676. Epub 2023 Nov 16.
2
"Faith and a sunny day": Association of patient frailty with strain experienced by informal caregivers of older adults with non-muscle-invasive bladder cancer.“信仰和晴天”:非肌肉浸润性膀胱癌老年患者的非正式照护者所经历的压力与患者脆弱性的关联。
J Geriatr Oncol. 2024 Nov;15(8):102060. doi: 10.1016/j.jgo.2024.102060. Epub 2024 Sep 7.
3
Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder cancer in older adults: A population-based analysis.老年人非肌层浸润性膀胱癌诊断后的老年病状况和治疗负担:基于人群的分析。
J Geriatr Oncol. 2021 Sep;12(7):1022-1030. doi: 10.1016/j.jgo.2021.04.005. Epub 2021 May 8.
4
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI.非肌肉浸润性膀胱癌患者自我报告症状指数(NMIBC-SI)的开发与心理测量学评估
J Patient Rep Outcomes. 2025 Mar 27;9(1):36. doi: 10.1186/s41687-025-00864-7.
5
A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer.非肌肉浸润性膀胱癌患者报告结局的概念框架。
Support Care Cancer. 2017 Oct;25(10):3095-3102. doi: 10.1007/s00520-017-3717-5. Epub 2017 Apr 27.
6
Patient experience and unmet needs in high-risk nonmuscle-invasive bladder cancer: Insights from qualitative interviews and a cross-sectional survey.高危非肌层浸润性膀胱癌患者的体验与未满足需求:来自定性访谈和横断面调查的见解
Urol Oncol. 2024 Mar;42(3):70.e1-70.e10. doi: 10.1016/j.urolonc.2024.01.013. Epub 2024 Jan 25.
7
Risk stratification and management of non-muscle-invasive bladder cancer: A physician survey in six Asia-Pacific territories.非肌肉浸润性膀胱癌的风险分层和管理:亚太六个地区的医生调查。
Int J Urol. 2024 Jan;31(1):64-71. doi: 10.1111/iju.15309. Epub 2023 Oct 6.
8
Overall burden and impact on health-related quality of life associated with intravesical treatment of patients with non-muscle invasive bladder cancer in the United States.美国非肌肉浸润性膀胱癌患者行膀胱内治疗的总体负担及对健康相关生活质量的影响。
Curr Med Res Opin. 2024 Nov;40(11):2003-2011. doi: 10.1080/03007995.2024.2411424. Epub 2024 Oct 7.
9
Association between frailty and overall survival among older adults with hepatocellular carcinoma.衰弱与老年肝细胞癌患者总体生存率的相关性。
J Geriatr Oncol. 2024 Sep;15(7):102045. doi: 10.1016/j.jgo.2024.102045. Epub 2024 Aug 10.
10
Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.卡介苗治疗前门诊针刺治疗高危非肌层浸润性膀胱癌患者的1/2期随机临床试验
Eur Urol Oncol. 2024 Dec;7(6):1431-1440. doi: 10.1016/j.euo.2024.04.002. Epub 2024 Apr 22.

引用本文的文献

1
"Faith and a sunny day": Association of patient frailty with strain experienced by informal caregivers of older adults with non-muscle-invasive bladder cancer.“信仰和晴天”:非肌肉浸润性膀胱癌老年患者的非正式照护者所经历的压力与患者脆弱性的关联。
J Geriatr Oncol. 2024 Nov;15(8):102060. doi: 10.1016/j.jgo.2024.102060. Epub 2024 Sep 7.

本文引用的文献

1
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.老年癌症系统治疗患者脆弱性的实用评估与管理:ASCO 指南更新。
J Clin Oncol. 2023 Sep 10;41(26):4293-4312. doi: 10.1200/JCO.23.00933. Epub 2023 Jul 17.
2
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial.评估 CCTG CO.17 试验中癌症治疗的时间毒性。
JCO Oncol Pract. 2023 Jun;19(6):e859-e866. doi: 10.1200/OP.22.00737. Epub 2023 Mar 7.
3
Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors.辅助化疗后老年乳腺癌幸存者的毒性风险评分和临床恶化。
J Natl Cancer Inst. 2023 May 8;115(5):578-585. doi: 10.1093/jnci/djad029.
4
Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study.在接受辅助化疗的老年乳腺癌患者中炎症与临床转归:Hurria 老年患者前瞻性研究的结果。
J Clin Oncol. 2023 Jan 10;41(2):307-315. doi: 10.1200/JCO.22.01217. Epub 2022 Sep 20.
5
Trends and Racial Disparities in the Prevalence of Urinary Incontinence Among Men in the USA, 2001-2020.2001 - 2020年美国男性尿失禁患病率的趋势及种族差异
Eur Urol Focus. 2022 Nov;8(6):1758-1767. doi: 10.1016/j.euf.2022.04.015. Epub 2022 May 11.
6
Burden of Treatment among Elderly Patients with Cancer: A Scoping Review.老年癌症患者的治疗负担:一项范围综述
Healthcare (Basel). 2021 May 19;9(5):612. doi: 10.3390/healthcare9050612.
7
Understanding Treatment Tolerability in Older Adults With Cancer.了解老年癌症患者的治疗耐受性
J Clin Oncol. 2021 Jul 1;39(19):2150-2163. doi: 10.1200/JCO.21.00195. Epub 2021 May 27.
8
Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder cancer in older adults: A population-based analysis.老年人非肌层浸润性膀胱癌诊断后的老年病状况和治疗负担:基于人群的分析。
J Geriatr Oncol. 2021 Sep;12(7):1022-1030. doi: 10.1016/j.jgo.2021.04.005. Epub 2021 May 8.
9
Factors influencing treatment burden in colorectal cancer patients undergoing curative surgery: A cross-sectional study.影响结直肠癌根治术患者治疗负担的因素:一项横断面研究。
Eur J Cancer Care (Engl). 2021 Sep;30(5):e13437. doi: 10.1111/ecc.13437. Epub 2021 Mar 9.
10
Prevalence of Urinary Incontinence among a Nationally Representative Sample of Women, 2005-2016: Findings from the Urologic Diseases in America Project.2005-2016 年全国女性尿失禁患病率:美国泌尿科疾病项目研究结果。
J Urol. 2021 Jun;205(6):1718-1724. doi: 10.1097/JU.0000000000001634. Epub 2021 Feb 19.

老年评估衍生的缺陷积累和老年膀胱癌患者的报告治疗负担。

Geriatric assessment-derived deficit accumulation and patient-reported treatment burden in older adults with bladder cancer.

机构信息

Department of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.

Biostatistics Core, Geisinger, Danville, Pennsylvania, USA.

出版信息

J Am Geriatr Soc. 2024 Feb;72(2):490-502. doi: 10.1111/jgs.18676. Epub 2023 Nov 16.

DOI:10.1111/jgs.18676
PMID:37974546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10922080/
Abstract

BACKGROUND

When a person's workload of healthcare exceeds their resources, they experience treatment burden. At the intersection of cancer and aging, little is known about treatment burden. We evaluated the association between a geriatric assessment-derived Deficit Accumulation Index (DAI) and patient-reported treatment burden in older adults with early-stage, non-muscle-invasive bladder cancer (NMIBC).

METHODS

We conducted a cross-sectional survey of older adults with NMIBC (≥65 years). We calculated DAI using the Cancer and Aging Research Group's geriatric assessment and measured urinary symptoms using the Urogenital Distress Inventory-6 (UDI-6). The primary outcome was Treatment Burden Questionnaire (TBQ) score. A negative binomial regression with LASSO penalty was used to model TBQ. We further conducted qualitative thematic content analysis of responses to an open-ended survey question ("What has been your Greatest Challenge in managing medical care for your bladder cancer") and created a joint display with illustrative quotes by DAI category.

RESULTS

Among 119 patients, mean age was 78.9 years (SD 7) of whom 56.3% were robust, 30.3% pre-frail, and 13.4% frail. In the multivariable model, DAI and UDI-6 were significantly associated with TBQ. Individuals with DAI above the median (>0.18) had TBQ scores 1.94 times greater than those below (adjusted IRR 1.94, 95% CI 1.33-2.82). Individuals with UDI-6 greater than the median (25) had TBQ scores 1.7 times greater than those below (adjusted IRR 1.70, 95% CI 1.16-2.49). The top 5 themes in the Greatest Challenge question responses were cancer treatments (22.2%), cancer worry (19.2%), urination bother (18.2%), self-management (18.2%), and appointment time (11.1%).

CONCLUSIONS

DAI and worsening urinary symptoms were associated with higher treatment burden in older adults with NMIBC. These data highlight the need for a holistic approach that reconciles the burden from aging-related conditions with that resulting from cancer treatment.

摘要

背景

当一个人的医疗工作量超过其资源时,他们就会面临治疗负担。在癌症和老龄化的交叉点上,对于老年早期非肌肉浸润性膀胱癌(NMIBC)患者的治疗负担知之甚少。我们评估了老年评估衍生的缺陷累积指数(DAI)与老年早期非肌肉浸润性膀胱癌(NMIBC)患者报告的治疗负担之间的关系。

方法

我们对老年 NMIBC 患者(≥65 岁)进行了横断面调查。我们使用癌症和老龄化研究组的老年评估计算了 DAI,并使用尿生殖窘迫量表-6(UDI-6)测量了尿症状。主要结局是治疗负担问卷(TBQ)评分。我们使用具有 LASSO 惩罚的负二项式回归来对 TBQ 进行建模。我们还对一个开放问题(“在管理膀胱癌的医疗护理方面,您最大的挑战是什么?”)的回答进行了定性主题内容分析,并根据 DAI 类别创建了一个联合展示,其中包含说明性引述。

结果

在 119 名患者中,平均年龄为 78.9 岁(SD 7),其中 56.3%为健壮,30.3%为脆弱前期,13.4%为脆弱。在多变量模型中,DAI 和 UDI-6 与 TBQ 显著相关。DAI 高于中位数(>0.18)的个体的 TBQ 评分比 DAI 低于中位数的个体高 1.94 倍(调整后的 IRR 1.94,95%CI 1.33-2.82)。UDI-6 大于中位数(25)的个体的 TBQ 评分比 UDI-6 低于中位数的个体高 1.7 倍(调整后的 IRR 1.70,95%CI 1.16-2.49)。在“最大挑战”问题回答中的前 5 个主题是癌症治疗(22.2%)、癌症担忧(19.2%)、排尿困扰(18.2%)、自我管理(18.2%)和预约时间(11.1%)。

结论

DAI 和恶化的尿症状与老年 NMIBC 患者的更高治疗负担相关。这些数据强调需要采用整体方法,协调与衰老相关疾病相关的负担与癌症治疗相关的负担。